Optimized Chronic Care for Smokers: Developing and Implementing Integrated Clinical and Systems Interventions in Primary Care

优化吸烟者的长期护理:在初级护理中制定和实施综合临床和系统干预措施

基本信息

  • 批准号:
    10415915
  • 负责人:
  • 金额:
    $ 289.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-01 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

Overall Summary Tobacco smoking is the leading preventable cause of cancer death. However, healthcare systems have not realized their potential to reduce smoking prevalence; far too few patients who smoke are offered and use smoking treatments and such treatments are insufficiently effective. This Program Project addresses these key obstacles by developing an especially effective comprehensive chronic care smoking treatment to reduce smoking prevalence in healthcare via 4 individual projects and 3 cores. This Program Project will balance internal and external validity via powerful, innovative research methods such as the Multiphase Optimization Strategy (MOST) while also using real-world primary care clinics, patients, and staff, and using the RE-AIM framework to enhance its public health impact. Using a factorial design, the Cessation Screening Project will evaluate four experimental factors in 608 smokers willing to quit to determine, for the first time, which intervention strategies (Preparation Medication, Extended Medication, and Counseling Modality) combine to produce especially effective Optimized Varenicline and Combination Nicotine Replacement Therapy (C-NRT) Treatment Packages based on cost and 1-year abstinence. The Health System Reach Interventions Project will, for the first time, use a factorial experiment to evaluate three interventions intended to increase the use of cessation treatments (i.e., reach) over 2 years in 1664 smokers initially unwilling to quit: 1) Monetary Incentives to Use Smoking Treatment, 2) Electronic Health Record (EHR) Based Automated Tailored Outreach, and 3) Care Management. An Optimized Reach Intervention Package will be developed that produces especially high rates of varenicline and C-NRT cessation treatment use by smokers initially unwilling to quit. The Optimized Care Project will comprise two randomized controlled trials (RCTs) that evaluate the Optimized Cessation and Reach Intervention Packages developed in the Cessation and Reach Projects. One RCT will compare Optimized Cessation Treatment versus Standard Care (physician & quitline referral) on 1-year abstinence in 600 smokers willing to quit. The second RCT will compare combined Optimized Reach and Cessation Interventions versus Standard Care on cessation treatment use and 1-year abstinence in 900 smokers initially unwilling to quit. The Implementation Project will assess the reach, implementation (fidelity, adaptation, relation with effectiveness), patient representativeness, and maintenance of interventions in the other 3 projects using EHR, survey, qualitative, and observational data at patient, staff, clinic, and system levels. This Program Project will be supported by Administration & Logistics, Data Analysis, and Optimization Cores and by shared resources: collaborating healthcare systems and recruitment via an enhanced EHR. This Program Project will develop a chronic care smoking treatment for healthcare that includes optimized reach and cessation interventions that can be readily implemented and disseminated and that markedly increase the use and effectiveness of cessation treatment, ultimately reducing smoking prevalence and cancer deaths.
总体汇总 吸烟是导致癌症死亡的主要可预防原因。然而,医疗保健系统并没有 意识到他们的潜力,以减少吸烟率;太少的吸烟患者提供和使用 吸烟治疗和这种治疗不够有效。该项目解决了这些关键问题。 通过开发一种特别有效的综合慢性护理吸烟治疗, 通过4个独立项目和3个核心,了解医疗保健中的吸烟流行率。该项目将平衡 通过强大的,创新的研究方法,如多阶段优化的内部和外部有效性 战略(MOST),同时也使用现实世界的初级保健诊所,病人和工作人员,并使用RE-AIM 加强其公共卫生影响的框架。采用析因设计,戒烟筛查项目将 评估了608名愿意戒烟的吸烟者的四个实验因素,首次确定, 干预策略(准备药物、扩展药物和咨询方式)结合联合收割机, 产生特别有效的优化伐尼克兰和尼古丁替代疗法(C-NRT) 治疗包基于成本和1年的禁欲。卫生系统干预项目 将首次使用析因实验来评估旨在增加使用的三种干预措施, 停止治疗(即,达到)2年以上的1664名吸烟者最初不愿意戒烟:1)金钱奖励 使用吸烟治疗,2)基于电子健康记录(EHR)的自动定制外展,以及3) 护理管理。将开发一个优化的到达干预包, 最初不愿意戒烟的吸烟者使用伐尼克兰和C-NRT戒烟治疗的比例。优化 护理项目将包括两项随机对照试验(RCT),评估优化的停药 和Reach干预包在停止和Reach项目中开发。一项RCT将比较 优化戒烟治疗与标准治疗(医生和戒烟热线转诊)对1年戒烟的影响 600名吸烟者愿意戒烟第二项RCT将比较优化达到和停止的组合 900名最初吸烟者的干预与标准治疗对戒烟治疗使用和1年戒烟的影响 不愿意放弃。实施项目将评估覆盖范围、实施(保真度、适应性、 与有效性的关系),患者代表性,以及其他3种干预措施的维持 在患者、员工、诊所和系统层面使用EHR、调查、定性和观察数据的项目。这 计划项目将得到行政与后勤、数据分析和优化核心的支持, 共享资源:通过增强的EHR协作医疗系统和招聘。这个程序 该项目将开发一种针对医疗保健的慢性护理吸烟治疗,包括优化覆盖范围, 容易实施和传播的戒烟干预措施, 和戒烟治疗的有效性,最终降低吸烟率和癌症死亡率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Timothy B Baker其他文献

Timothy B Baker的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Timothy B Baker', 18)}}的其他基金

E-Cigarette Effects ON Markers of Cardiovascular AND Pulmonary Disease Risk
电子烟对心血管和肺部疾病风险标志物的影响
  • 批准号:
    10245273
  • 财政年份:
    2018
  • 资助金额:
    $ 289.27万
  • 项目类别:
Testing Relapse Recovery Intervention Components
测试复发恢复干预成分
  • 批准号:
    8655747
  • 财政年份:
    2014
  • 资助金额:
    $ 289.27万
  • 项目类别:
Optimized Chronic Care for Smokers: Developing and Implementing Integrated Clinical and Systems Interventions in Primary Care
优化吸烟者的长期护理:在初级护理中制定和实施综合临床和系统干预措施
  • 批准号:
    10627882
  • 财政年份:
    2014
  • 资助金额:
    $ 289.27万
  • 项目类别:
Optimized Chronic Care for Smokers: Developing and Implementing Integrated Clinical and Systems Interventions in Primary Care
优化吸烟者的长期护理:在初级护理中制定和实施综合临床和系统干预措施
  • 批准号:
    10215407
  • 财政年份:
    2014
  • 资助金额:
    $ 289.27万
  • 项目类别:
Enhancing the Effectiveness of Varenicline Based Smoking Cessation Treatment
提高基于伐尼克兰的戒烟治疗的有效性
  • 批准号:
    9311480
  • 财政年份:
    2011
  • 资助金额:
    $ 289.27万
  • 项目类别:
Intervention Optimization Core
干预优化核心
  • 批准号:
    7612555
  • 财政年份:
    2009
  • 资助金额:
    $ 289.27万
  • 项目类别:
Identifying Optimal, Translatable Tobacco Cessation Interention Components
确定最佳的、可转化的戒烟干预成分
  • 批准号:
    7612559
  • 财政年份:
    2009
  • 资助金额:
    $ 289.27万
  • 项目类别:
Training in Translational Tobacco Science
转化烟草科学培训
  • 批准号:
    7918941
  • 财政年份:
    2008
  • 资助金额:
    $ 289.27万
  • 项目类别:
Training in Translational Tobacco Science
转化烟草科学培训
  • 批准号:
    7689810
  • 财政年份:
    2008
  • 资助金额:
    $ 289.27万
  • 项目类别:
Training in Translational Tobacco Science
转化烟草科学培训
  • 批准号:
    8324683
  • 财政年份:
    2008
  • 资助金额:
    $ 289.27万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 289.27万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 289.27万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 289.27万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 289.27万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 289.27万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 289.27万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 289.27万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 289.27万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 289.27万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 289.27万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了